Encouraging Early Data From Next-Gen Study Puts Bristol Myers' CAR T Therapy In The Spotlight For Autoimmune Diseases

By Yahoo! Finance | Nov 18, 2024 at 01:24 PM EST

Bristol Myers Squibb shared promising data on CC-97540, a new CAR T Cell Therapy for autoimmune diseases, at ACR 2024. Manufactured using NEX-TTM process, it showed positive safety and efficacy results, demonstrating potential as a key growth driver for the company.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.